Metraipolis › archive › dc_52480df2a0bd
Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs — Europe PMC PMID:42344916
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42344916
- DOI
- 10.3389/fimmu.2026.1847913
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T16:02:40.631Z
- SHA-256 of the archived text
7cc310d6d78c1581ba18582b0a4a725ddf3c252eb76b2aefd2bac26c85cf8945- Stable URL of this page
https://metraipolis.com/documento/dc_52480df2a0bd
How to cite
Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs — Europe PMC PMID:42344916 — Europe PMC (en), https://europepmc.org/article/MED/42344916 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_52480df2a0bd (Metraipolis archive dc_52480df2a0bd, sha256 7cc310d6d78c1581ba18582b0a4a725ddf3c252eb76b2aefd2bac26c85cf8945)
BibTeX
@misc{dc52480df2a0bd,
title = {Antibody-based regimens targeting PD-1/PD-L1 and VEGF/VEGFR in advanced or metastatic NSCLC: a meta-analysis of RCTs — Europe PMC PMID:42344916},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42344916},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_52480df2a0bd; sha256 7cc310d6d78c1581ba18582b0a4a725ddf3c252eb76b2aefd2bac26c85cf8945},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42344916. Agents can read the archived copy with the MCP tool read_document.